Zdrowie i gospodarka · 29/07/1997

FDA Proposes Revision to Good Manufacturing Practice Regulations for Drug Labeling

The FDA is proposing to update its Good Manufacturing Practice (CGMP) regulations for human and veterinary drug products to improve labeling control and prevent errors that could lead to adverse health consequences, while also reducing regulatory burden on manufacturers.